$ACT Company News Actavis continues hot streak with

New Post Public Reply Private Reply Replies (0) Message Board

Feb 21, 2014 at 10:44 AM

$ACT Company News

Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Investors drive up price of Actavis-Forest deal 11:14 a.m. Feb. 18, 2014 - blogs.marketwatch.com
Actavis shares jump 7.8% on Forest Lab deal 9:35 a.m. Feb. 18, 2014 - Sue Chang
U.S. stock futures trim rise; Forest Labs soars 9:14 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis-Forest Labs is play on changes in health care 9:06 a.m. Feb. 18, 2014 - Dana Mattioli
Actavis confirms $25 bln Forest Labs acquistion 7:15 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis shares climb 10% on deal for Forest Labs 7:12 a.m. Feb. 18, 2014 - Silvia Ascarelli
Forest Lab surges 27% premarket on Actavis deal 7:09 a.m. Feb. 18, 2014 - Silvia Ascarelli
Actavis confirms $25 bln Forest Labs acquistion 7:02 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis in talks to buy Forest Labs for up to $25 bln 1:06 a.m. Feb. 18, 2014 - Dana Mattioli, Jonathan D. Rockoff and Dana Cimilluca
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Bears chip away at the S&P 1,775 support 11:00 a.m. Feb. 3, 2014 - Michael Ashbaugh

Actavis Up on Strong 4Q Earnings Beat - Analyst Blog 57 min ago - Zacks.com
This Biotech Bubble Is Bound to Burst 3:28 a.m. Today - InvestorPlace.com
Actavis PLC (ACT): Today's Featured Health Care Winner 5:00 p.m. Feb. 20, 2014 - TheStreet.com
Shares of M&A Bidders Enjoy Rare Burst of Buying 12:00 p.m. Feb. 20, 2014 - FOXBusiness
Actavis Q4 Beats Street; Guidance Affirmed For Now 10:21 a.m. Feb. 20, 2014 - Investors Business Daily
More on Actavis Q4: Warner Chilcott boosts revenue 8:44 a.m. Feb. 20, 2014 - Seeking Alpha
UPDATE: Actavis Posts Upbeat Q4 Earnings 7:48 a.m. Feb. 20, 2014 - benzinga.com
Actavis Swings to Loss on Restructuring, Write-Downs 7:33 a.m. Feb. 20, 2014 - WSJ.com
Notable earnings before Thursday’s open 12:05 a.m. Feb. 20, 2014 - Seeking Alpha
Notable earnings before Thursday’s open 5:30 p.m. Feb. 19, 2014 - Seeking Alpha
Is It Too Soon To Call 2014 A Year Of Mergers And Acquisitions? 5:18 p.m. Feb. 19, 2014 - TheStreet.com
Medicals Among Top 20 Groups, Retailers Near Bottom 5:07 p.m. Feb. 19, 2014 - Investors Business Daily
Top-Ranked Forest Labs Soars on Buyout News - Analyst Blog 3:45 p.m. Feb. 19, 2014 - Zacks.com
After Forest Deal, Actavis Could Climb 50% 10:53 a.m. Feb. 19, 2014 - Barrons.com
Today's Unusual Social Activity Stock: Actavis (ACT) 10:15 a.m. Feb. 19, 2014 - TheStreet.com
Stock Market News for February 19, 2014 - Market News 10:06 a.m. Feb. 19, 2014 - Zacks.com
Is Weather the Only Explation? - Ahead of Wall Street 9:46 a.m. Feb. 19, 2014 - Zacks.com
Is Weather the Only Explanation? - Ahead of Wall Street 9:46 a.m. Feb. 19, 2014 - Zacks.com
UPDATE: Bank of America Reiterates on Actavis on Possible Forest Acquisition 8:48 a.m. Feb. 19, 2014 - benzinga.com
The Market Rally Resembles a Dog On a Bone 5:59 a.m. Feb. 19, 2014 - InvestorPlace.com

Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013; Non-GAAP EPS Increases 99% to $3.17 7:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Actavis to Present at Citi's 2014 Global Healthcare Conference 4:25 p.m. Feb. 19, 2014 - PR Newswire - PRF
Critical Alerts For Actavis, athenahealth, Seattle Genetics, JP Morgan Chase, and SodaStream Released By InvestorsObserver 9:31 a.m. Feb. 19, 2014 - PR Newswire - PRF
Actavis to buy Forest Labs for $25B and GT Advanced Tech acquires exclusive rights from Kyma Tech 12:31 a.m. Feb. 19, 2014 - ACCESSWIRE
Acquisition of Forest Laboratories, Inc. by Actavis plc May Not Be in Shareholders' Best Interests 9:02 p.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Cancel Q4 and FY 2013 Earnings Call Previously Scheduled for Thursday, February 20, 2014 5:13 p.m. Feb. 18, 2014 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Forest Laboratories, Inc. Stockholders 5:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Forest Labs Acquisition; Outlook Stable 2:52 p.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST SHAREHOLDERS NOTICE:Johnson & Weaver, LLP Announces Investigation of the Forest Laboratories, Inc. Proposed Acquisition by Actavis plc 9:43 a.m. Feb. 18, 2014 - BusinessWire - BZX
INVESTOR BUYOUT ALERT - Offer to Acquire Forest Laboratories - Shareholder Rights Law Firm Tripp Levy PLLC Seeks Higher Price And More Information For Shareholders 8:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Host Fourth Quarter 2013 Earnings Conference Call and Webcast 8:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Actavis Confirms Generic Treanda® Patent Challenge 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
Actavis Presents Outlook for Continued Long-Term Growth 7:15 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Refocused Global Business Structure to Maximize Evolution into Global Specialty Pharmaceuticals Leadership 7:00 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Zhejiang Chiral Medicine Chemicals Co., Ltd to Divest Actavis Foshan, China 4:05 p.m. Jan. 24, 2014 - PR Newswire - PRF
Actavis Comments on Notification to Allergan, Inc. of Submission of Application for Restasis® 12:41 p.m. Jan. 22, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries 9:45 p.m. Jan. 17, 2014 - PR Newswire - PRF
Actavis Confirms Court Upholds Lo Loestrin® Fe Patent 5:42 p.m. Jan. 17, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CIMAMotor 2026: A Massive Gathering in Motorcycle Mecca

Unprecedented Scale at CIMAMotor 2026 Come September, the 24th China International Motorcycle Trade Exhibition, also known as CIMAMotor 2026, is set to roar through the corridors of the Chongqing International Expo Center. With more than 1,000 exhibitors and over 3,000 vehicles on display, it’s clear this isn’t just another trade show—this is a full-blown spectacle...

York Space Systems Faces Class Action Over Misleading IPO

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

NeuralTrust Expands to London as AI Risks Intensify

NeuralTrust's Strategic London Expansion In a world where AI agents are sprinting ahead of our security instincts, NeuralTrust makes a big play in the UK market, locking in their position with a new London office. This move isn't just about expansion—it's about tackling the tide of challenges head-on that comes with putting AI agents into the wild. London: A Hub for...

Kickstart into a Faith-Fueled Tale Out of Lillington, N.C. comes a novel that isn't just pages of printed text, but almost a life lesson wrapped in fiction. Lee Jennings serves up "Home in Montana," a Christian romance mystery that throws a kaleidoscope of emotions onto the reader's lap, whether they're relaxed in a recliner or flipping through it on their lunch break....

TECNO CAMON Slim 5G: Where Art Meets Tech

Unveiling the TECNO CAMON Slim 5G Okay, so imagine a tech brand saying, 'Why not make a phone that’s as much an art piece as it is a gadget?' TECNO just pulled this off with their latest CAMON Slim 5G. The thing's a sleek marvel measuring in at just 6.39mm. Seems like they took a fat-free diet approach to phone design, and not on the digital calories either. A Slim Body...

Hoymiles' V2X Charger Revamps Home Energy Control

Revolutionizing Home Energy with Hoymiles Here's a twist in the world of home energy that'll make any enthusiast pause—Hoymiles has launched their V2X DC Charger. This little number isn’t just a step up; it’s a giant leap toward integrating electric vehicles (EVs) into your home's energy system like never before. Nestled in Hangzhou, they've rolled this out as a...

Baidu's Stock Connect Inclusion: What It Means for Investors

An Intriguing Move For Baidu's Class A Shares Well, here we go again, folks. Another move on the chessboard for Baidu. They've just walked their Class A ordinary shares onto the Shenzhen-Hong Kong and Shanghai-Hong Kong Stock Connects. As of today, September 7, 2026, mainland investors can now get their mitts on these shares more easily. It might not be a...

Hyosung Targets U.S. AI Power Market with Advanced SST

Hyosung's Game-Changing Move in the AI Power Sector Guess what? The AI era's heating up, and it's dragging the power sector along for a wild ride. Hyosung Chairman Hyun-Joon Cho peered into that future and decided it's all-in time for the U.S. power market. With AI and data centers cranking up power demands like never before, those rickety old wires need an upgrade fast....

GBC 2026 Wraps Up: Korea Eyes Bio Industry Leadership

GBC 2026: Korea's Giant Leap in Bio Innovation Well, there wasn't a dull moment at the 'Global Bio Conference 2026' in Seoul. Picture a melting pot where 5,600 participants from 19 countries converged to chat about the latest and greatest in biopharma innovation and regulatory strategies. That's not a setup you see every day, mind you. This event packed the room with...

Ping An Climbs Sustainability Ladder, Scores A+ Rating

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...